Peter Verhaeghe graduated magna cum laude in law from the Katholieke Universiteit Leuven in 1981. He earned his LL.M. at Harvard Law School in 1984. His areas of expertise include corporate, corporate finance, contract and tax law. He has extensive industry related experience and knowledge in the biotech, pharmaceutical, consumer products, retail and media sectors of the economy.

Peter is the managing partner of VVGB Advocaten-Avocats, a corporate finance law and tax law firm (Brussels, Belgium), a position he has held since July 1999. He is currently lead counsel to a number of Belgian, Dutch, French, U.S. and Swiss life sciences companies. He has served on the boards of directors of Participatiemaatschappij Vlaanderen NV since May 2018 and miDiagnostics NV since April 2020. He has also served as chairman of the board of Haretis SA (Luxembourg) since March 2011 and as chairman of the LP & advisory committee of Bioqube Factory Fund I NV since September 2020. Peter previously served as a member of the board of directors of CzechPak Manufacturing s.r.o., Innogenetics NV (now Fujirebio Europe N.V.), Tibotec-Virco NV, and Biocartis SA. He was also the president of the board of directors of Merisant France SAS, a member of the management board of Merisant Company 2 S.à. rl., and chairman of the board of directors of PharmaNeuroBoost NV. Peter has served as a member and chairperson of the board of arGEN-X B.V. since October 2008 and as Non-Executive Director on the Board of Directors from July 2014 until January 2026.